Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $9.55B | 10.72% |
46,569,190
+15,521,860
| +50% | +$3.26B |
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $7.21B | 8.1% |
35,191,537
+13,911,996
| +65% | +$2.93B |
|
|
3
PUT
iShares Russell 2000 ETF
IWM
$81.2B
| $3.23B | 3.62% |
26,026,300
+5,339,100
| +26% | +$667M |
|
|
4
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $2.42B | 2.72% |
11,828,140
+2,299,700
| +24% | +$484M |
|
|
5
PUT
Bausch Health
BHC
$1.66B
| $1B | 1.12% |
4,510,900
-2,082,800
| -32% | -$462M |
|
|
6
Bausch Health
BHC
$1.66B
| $859M | 0.96% |
3,868,637
-2,182,040
| -36% | -$484M |
|
|
7
CALL
iShares Russell 2000 ETF
IWM
$81.2B
| $832M | 0.93% |
6,713,600
-882,800
| -12% | -$110M |
|
|
8
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $802M | 0.9% |
20,558,100
+13,174,100
| +178% | +$551M |
|
|
9
iShares Russell 2000 ETF
IWM
$81.2B
| $736M | 0.83% |
5,939,108
+1,750,129
| +42% | +$219M |
|
10
Apple
AAPL
$4.72T
| $691M | 0.78% |
22,099,652
+475,804
| +2% | +$15.2M |
|
|
11
CALL
Apple
AAPL
$4.72T
| $667M | 0.75% |
21,339,480
-2,973,760
| -12% | -$95.1M |
|
|
12
Johnson & Johnson
JNJ
$624B
| $658M | 0.74% |
6,779,300
+2,094,332
| +45% | +$210M |
|
|
13
PUT
Apple
AAPL
$4.72T
| $645M | 0.72% |
20,641,000
+7,514,840
| +57% | +$240M |
|
14
PUT
Bank of America
BAC
$430B
| $473M | 0.53% |
27,850,700
+21,665,900
| +350% | +$357M |
|
|
15
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $451M | 0.51% |
11,568,400
-4,088,900
| -26% | -$171M |
|
16
IBM
IBM
$194B
| $444M | 0.5% |
2,867,798
+1,229,922
| +75% | +$198M |
|
17
Microsoft
MSFT
$2.83T
| $416M | 0.47% |
9,450,372
-1,802,105
| -16% | -$82.2M |
|
18
Pfizer
PFE
$143B
| $415M | 0.47% |
13,240,025
+1,389,403
| +12% | +$45.3M |
|
19
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $413M | 0.46% |
4,692,700
+3,347,900
| +249% | +$303M |
|
|
20
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $409M | 0.46% |
10,490,087
+7,092,078
| +209% | +$297M |
|
21
ExxonMobil
XOM
$650B
| $403M | 0.45% |
4,849,841
+842,775
| +21% | +$72.5M |
|
22
PUT
iShares China Large-Cap ETF
FXI
$4.29B
| $401M | 0.45% |
8,715,800
-1,550,500
| -15% | -$76.8M |
|
23
PUT
Gilead Sciences
GILD
$162B
| $387M | 0.43% |
3,305,700
-1,246,100
| -27% | -$136M |
|
|
24
Bank of America
BAC
$430B
| $382M | 0.43% |
22,498,762
+5,710,543
| +34% | +$94.1M |
|
|
25
AT&T
T
$160B
| $369M | 0.41% |
13,975,584
-10,807,168
| -44% | -$279M |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.